To determine whether Drp1 is a key protein regulating ROCK2-induced ferroptosis, which leads to the resistance of CCA cells to Pemigatinib, we decreased Drp1 levels in ROCK2-overexpressing cells and observed changes in resistance to Pemigatinib using CCK-8 assays. The gene discussed is ROCK2; the disease is cholangiocarcinoma.